ASX:ENPPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
ENTROPY NEURODYNAMICS ORD
$0.036
$0.002 (5.26%)
Day Range
$0.036 - $0.038
52 Week Range
$0.025 - $0.046
Volume
1.01M
Avg Volume (10D)
3.16M
Market Cap
$56.92M
Price Chart
Market Statistics
Open$0.037
Previous Close$0.038
Day High$0.038
Day Low$0.036
52 Week High$0.046
52 Week Low$0.025
Valuation
Market Cap56.92M
Shares Outstanding1.58B
Price to Book7.90
Trading Activity
Volume1.01M
Value Traded37.76K
Bid$0.036 × 471,679
Ask$0.037 × 459,672
Performance
1 Day8.33%
5 Day6.85%
13 Week21.88%
52 Week2.63%
YTD18.18%
Technical Indicators
RSI (14)53.64
50-Day SMA$0.033
200-Day SMA$0.034
Latest News
Biotechnology
Entropy Neurodynamics Reports Breakthrough Results from Phase 2a TRP-8802 Study for Treating IBS
Entropy Neurodynamics announces Phase 2a TRP-8802 IBS results: 75% responders, clear gut-brain axis effect; de-risks program ahead of TRP-8803 trials.
2 min read
Biotechnology
Entropy Neurodynamics' TRP-8803 Trial Shows Repeatable Psychedelic Effects in BED Study
Entropy Neurodynamics reports repeatable psychedelic effects in TRP-8803 BED trial; Cohort 2 enrollment advancing; R&D incentives boost cash runway.
1 min read
Biotechnology
Entropy Neurodynamics Granted Australian Patent for TRP8803 to Treat Chronic Pain and Psychiatric Conditions
Entropy Neurodynamics (ASX: ENP) granted Australian patent for TRP8803 (IV psilocybin) for chronic pain and neuropsychiatric disorders; protection to 2042.
1 min read